U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07506642) titled 'Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)' on March 23.
Brief Summary: Patient Experience in Endohepatology Liver biopsy is a crucial procedure for the diagnosis and/or staging of liver diseases. Common indications for non-targeted biopsies include unexplained elevated liver function tests (LFTs), guiding medical therapy in autoimmune liver diseases or following liver transplantation (LT), and prognostic assessment in ambiguous clinical situations, occasionally within the scope of research.
Traditionally, there are three primary routes for obtaining liver biopsies: percutaneous liver biopsy (PC-LB), transjugu...